| ROCK2 — Rho-associated protein kinase 2 | |
|---|---|
| Symbol | ROCK2 |
| Full Name | Rho-associated protein kinase 2 |
| Chromosome | 2p25.1 |
| NCBI Gene | 9455 |
| Ensembl | ENSG00000134318 |
| OMIM | 604002 |
| UniProt | O75116 |
| Diseases | Alzheimer's Disease, Parkinson's Disease |
| Expression | Brain, Heart, Liver |
ROCK2 is a gene implicated in neurodegenerative diseases. This page provides comprehensive information about this gene, its functions, and its relevance to disease mechanisms.
ROCK2 is a serine/threonine kinase that mediates Rho GTPase signaling. It regulates actin cytoskeleton dynamics, cell contraction, and migration. ROCK2 has been implicated in synaptic plasticity, tau phosphorylation, and neuronal death in neurodegenerative diseases.
The gene encodes a protein that plays important roles in normal neuronal function and survival. Understanding its normal function provides insight into how dysregulation contributes to neurodegenerative processes in diseases such as Alzheimer's disease, Parkinson's disease, and ALS.
ROCK2 encodes a protein involved in various cellular processes relevant to neuronal health. The protein localizes to specific cellular compartments and participates in signaling pathways that regulate:
ROCK2 is expressed in Brain, Heart, Liver. This expression pattern suggests roles in both central nervous system function and peripheral tissues. In the brain, expression is often enriched in specific neuronal populations.
Alterations in ROCK2 expression or function have been reported in Alzheimer's disease brain tissue. Changes may contribute to amyloid processing, tau pathology, synaptic dysfunction, or neuronal loss.
ROCK2 has been implicated in Parkinson's disease pathogenesis through roles in dopaminergic neuron survival, protein aggregation, or mitochondrial dysfunction.
Depending on its specific function, ROCK2 may also play roles in other neurodegenerative conditions including ALS, Huntington's disease, and frontotemporal dementia.
Understanding the role of ROCK2 in neurodegeneration may lead to therapeutic strategies targeting: